PHAXIAM THERAPEUTICS S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.915 EUR | -1.19% |
|
0.00% | -36.63% |
Chart calendar PHAXIAM Therapeutics S.A.
1.INKlyiRg_WVpkRWo5MrSBNt9qYqjIRJzhgK4KaNmdXs.FeDUiEEXqRIu30eer7iQU7Ay-eLUa2sS8G7SUJAXPAtl4f25bwWvDyvWLQ~30a87ffc364d8c06fb529423f3a6ee8f
Upcoming events on PHAXIAM Therapeutics S.A.
Past events on PHAXIAM Therapeutics S.A.
| 2024-03-21 09:30 am | Q4 2023 Earnings Call |
| 2024-03-20 01:00 pm | Q4 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 4,45 4,78 -7.05% | 5,28 5,46 -3.25% | 3,72 7,69 -51.63% | 4,18 7,95 -47.4% | 31,0 9,20 236.93% | 0,00 0,00 - |
|
EBITDA Million EUR | Released Forecast Spread | -42,8 -43,8 2.23% | -59,9 -51,2 -16.99% | -63,8 -32,6 -95.83% | -51,1 -70,4 27.36% | 1,82 -52,6 103.47% | 0,00 -25,3 - |
|
EBIT Million EUR | Released Forecast Spread | -43,6 -45,1 3.27% | -64,1 -58,0 -10.4% | -68,8 -62,4 -10.24% | -56,5 -62,9 10.12% | -2,80 -52,6 94.68% | -23,7 -25,9 8.65% |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -38,2 -43,8 12.74% | -62,7 -57,7 -8.52% | -73,3 -63,7 -15.06% | -53,8 -57,3 6.18% | 0,00 0,00 - | 0,00 0,00 - |
|
Net income Million EUR | Released Forecast Spread | -38,2 -46,1 17.14% | -62,7 -57,5 -8.92% | -73,3 -63,7 -15.06% | -53,8 -62,1 13.41% | -0,23 -52,8 99.57% | -23,5 -26,0 9.66% |
|
EPS EUR | Released Forecast Spread | -21,3 -25,7 17.25% | -34,9 -29,6 -17.73% | -39,9 -29,1 -37.11% | -22,7 -39,0 41.79% | -0,10 -22,3 99.55% | 0,00 -4,28 - |
| Announcement Date | 11/03/19 | 16/03/20 | 08/03/21 | 27/04/22 | 22/03/23 | 20/03/24 |
Quarterly results
| Fiscal Period | December | 2019 S1 | 2019 S2 | 2020 S1 | 2020 S2 | 2021 Q2 | 2021 S1 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 S1 | 2022 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 2,97 1,60 85.31% | 2,32 2,60 -10.85% | 1,85 1,60 15.56% | 1,87 1,90 -1.63% | 0,83 1,25 -33.6% | 2,27 1,10 106.36% | 1,13 1,25 -9.6% | 0,96 1,25 -23.2% | 0,54 1,75 -69.2% | 0,47 | |
|
EBITDA Million EUR | Released Forecast Spread | -29,2 -25,3 -15.22% | -30,7 -27,1 -13.31% | -33,6 -28,5 -18% | -31,0 -31,3 1.02% | -26,5 -31,0 14.61% | ||||||
|
EBIT Million EUR | Released Forecast Spread | -30,2 -26,2 -15.44% | -33,8 -28,4 -19.12% | -35,4 -30,2 -17.12% | -33,5 -31,7 -5.56% | -15,7 -14,2 -10.4% | -29,0 -33,7 14.05% | -14,6 -15,5 5.57% | -13,8 -14,1 2.61% | -12,5 -13,7 8.35% | ||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -29,3 -25,9 -13.07% | -33,4 -28,2 -18.35% | -35,0 -30,3 -15.39% | -38,3 -31,6 -21.31% | -16,0 -13,3 -19.98% | -28,0 -34,6 19.22% | -13,6 -15,4 11.23% | -14,0 | -11,9 -13,6 12.37% | ||
|
Net income Million EUR | Released Forecast Spread | -29,3 -25,9 -13.07% | -33,4 -28,2 -18.34% | -35,0 -30,3 -15.39% | -38,3 -31,6 -21.32% | -16,0 -13,3 -20% | -28,0 -34,6 19.21% | -13,6 -15,4 11.23% | -14,0 | -11,9 -13,6 12.37% | -1,02 | -5,14 |
|
EPS EUR | Released Forecast Spread | -16,3 -14,0 -16.43% | -18,6 -16,0 -16.25% | -19,5 -17,0 -14.71% | -20,4 -17,0 -20% | -12,2 -17,0 28.24% | -0,30 | |||||
| Announcement Date | 17/09/19 | 16/03/20 | 21/09/20 | 08/03/21 | 20/09/21 | 20/09/21 | 21/11/22 | 27/04/22 | 12/05/22 | 12/09/22 | 21/11/22 |
More events
Past sector events for PHAXIAM Therapeutics S.A.
| 2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PHXM Stock
- PHXM Stock
- Calendar PHAXIAM Therapeutics S.A.
